Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial
Once reconstituted, refrigerated storage extends usable duration
Side effects in women occurred at slightly higher rates than in men, primarily for nausea
These combined actions lead to improved glycemic control in people with diabetes and significant weight loss in both diabetic and non-diabetic individuals
Dosing Protocol and Administration Injectable Retatrutide is administered once weekly using a subcutaneous injection, typically in the abdomen, thigh, or upper arm
Retatrutides Potential Benefits for PCOS The medications effects on insulin sensitivity may provide particular benefit for PCOS patients